Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: OrthoLogic

This article was originally published in The Gray Sheet

Executive Summary

OrthoLogic: Expanding patient enrollment in clinical trials of the OrthoLogic 1000 bone growth stimulator "to establish conclusive statistical significance" of the device's effectiveness in treating delayed union fractures, the company says. Results from the first 106 fractures showed that 62.5 % of the patients with OrthoLogic 1000 devices healed as opposed to 55.2% of the subjects that received placebo devices. While the data obtained from the study shows a positive effect, "the healing rate in the placebo group was greater than originally anticipated," according to an OrthoLogic press release. OrthoLogic received PMA approval for the product to treat nonunion fractures in March of 1994 ("The Gray Sheet" March 14, 1994, p. 4). ..

You may also be interested in...

Basilea Stresses Derazantinib's FGFR Kinase Differentiation

Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.


ATMPs Put EU Cross-Border Healthcare On The Map

Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.

Start-Up Snapshot: Nanomedic’s Electro-Spinning, Portable Wound Care Device

At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts